Search Results

You are looking at 251 - 260 of 534 items for :

  • "pathology" x
  • Refine by Access: All x
Clear All
Full access

Lucas Vieira dos Santos, João Paulo Lima, Kathia Cristina Abdalla, Arinilda Campos Bragagnoli, Florinda Almeida Santos, Alexandre dos Anjos Jácome, and Fabiano Elias Porto

-hematological toxicity during treatment with imatinib in patients with early and late chronic phase chronic myeloid leukemia . Leuk Lymphoma 2008 ; 49 : 2328 – 2332 . 11. Miettinen M Lasota J . Gastrointestinal stromal tumors: pathology and prognosis at

Full access

Justin Lee, Jennifer Axilbund, W. Brian Dalton, Daniel Laheru, Stanley Watkins, David Chu, Karen Cravero, Berry Button, Kelly Kyker-Snowman, Ian Waters, Christopher D. Gocke, Josh Lauring, and Ben Ho Park

circumferential mass around the duodenum. She underwent a pancreaticoduodenectomy (Whipple) procedure, with pathology showing a 3.0-cm moderately to poorly differentiated duodenal adenocarcinoma. Of 28 lymph nodes, 6 were positive for disease. The patient

Full access

Robert W. Carlson, D. Craig Allred, Benjamin O. Anderson, Harold J. Burstein, W. Bradford Carter, Stephen B. Edge, John K. Erban, William B. Farrar, Andres Forero, Sharon Hermes Giordano, Lori J. Goldstein, William J. Gradishar, Daniel F. Hayes, Clifford A. Hudis, Britt-Marie Ljung, David A. Mankoff, P. Kelly Marcom, Ingrid A. Mayer, Beryl McCormick, Lori J. Pierce, Elizabeth C. Reed, Jasgit Sachdev, Mary Lou Smith, George Somlo, John H. Ward, Antonio C. Wolff, and Richard Zellars

available online and not published in this issue are sections of the guidelines on noninvasive breast cancer and special considerations in breast cancer. Pathology Assessment A central component of the treatment of breast cancer is full knowledge of

Full access

Paul F. Engstrom, Juan Pablo Arnoletti, Al B. Benson III, Jordan D. Berlin, J. Michael Berry, Yi-Jen Chen, Michael A. Choti, Harry S. Cooper, Raza A. Dilawari, Dayna S. Early, Peter C. Enzinger, Marwan G. Fakih, James Fleshman Jr., Charles Fuchs, Jean L. Grem, James A. Knol, Lucille A. Leong, Edward Lin, Mary F. Mulcahy, Eric Rohren, David P. Ryan, Leonard Saltz, David Shibata, John M. Skibber, William Small Jr., Constantinos Sofocleous, James Thomas, Alan P. Venook, and Christopher Willett

persistent infection with a high-risk form of HPV (e.g., HPV-16 or -18) is believed to be strongest. 4 , 6 , 7 For example, a study of tumor specimens from 60 pathology laboratories showed that HPV-16 was detected in 84% and 0% of anal and rectal cancer

Full access

Philip E. Castle

-diagnosed cervical intraepithelial neoplasia grade 2 to the quality control pathology-reviewed diagnoses: an ALTS report . Am J Clin Pathol 2007 ; 127 : 805 – 815 . 79. Stoler MH Castle PE Solomon D Schiffman M . The expanded use of HPV testing in

Full access

Judd E. Cummings, J. Andrew Ellzey, and Robert K. Heck

on radiology, pathology and clinical biology. I. The intramedullary cartilage tumors . Skeletal Radol 1997 ; 26 : 325 – 353 . 37. Simon MA Krichner PT . Scintigraphic evaluation of primary bone tumors. Comparison of technetium-99m

Full access

, aggressive cancer that occurs in the lining of the abdomen (peritoneum) in approximately 600 patients every year in the United States. The new guidelines include an extensive section on the specific pathology tests that can be used to accurately identify MPeM

Full access

Meic H. Schmidt, Paul Klimo Jr, and Frank D. Vrionis

: 620 – 633 . 92 Koehler P Verbiest H Jager J . Delayed radiation myelopathy: serial MR-imaging and pathology . Clin Neurol Neurosurg 1996 ; 98 : 197 – 201 . 93 Tan B Hkor T . Radiation myelitis in carcinoma of the nasopharynx

Full access

Natasha Hunter, Sarah Croessmann, Karen Cravero, Daniel Shinn, Paula J. Hurley, and Ben Ho Park

paucity of tissue. However, the pathology report from the fine-needle aspiration biopsy was consistent with metastatic breast cancer from the original primary tumor (see supplemental eAppendix 1 , available with this article at JNCCN.org ). In addition

Full access

, Department of Pathology at MSK. “This collaboration with Tempus will help us share the frequently updated, evidence and expert consensus-based recommendations in the NCCN Guidelines more seamlessly with healthcare providers,” said Robert W. Carlson, MD